Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Hoffmann-La Roche
Age
18–any
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Adult patients, \>/= 18 years of age
Chronic kidney disease, on dialysis for \> 3 months
Treatment-naïve or previous treatment with ESA
Initiation of treatment with Mircera for renal insufficiency associated anemia by decision of the treating physician
You may not be if
Participation in a clinical trial
Anemia due to an associated malignant pathology
Clareo Health | An Observational Study of Mircera (Methoxy Polyethylene Glycol-Epoetin Beta) in Patients With Chronic Kidney Disease on Dialysis (HORTENSIA)
